Navigation Links
Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China
Date:10/22/2007

Dr. Rene Bruno Will Present on the Value of Clinical Trial Simulations to

Predict Efficacy and Survival Benefit of Anticancer Agents

MOUNTAIN VIEW, Calif., Oct. 22 /PRNewswire-FirstCall/ -- Pharsight Corporation (OTC Bulletin Board: PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced that Rene Bruno, Ph.D., managing director, Strategic Consulting Services, Europe, has been invited to speak to academics, regulators, and members of the Chinese pharmaceutical industry attending the International Symposium in Quantitative Pharmacology in Drug Development and Regulation. The symposium will be held in Nanjing China at the International Conference Hotel from October 29-31, 2007.

Dr. Bruno will join other leading experts from industry, government and academia in a scientific program that will discuss the latest methodologies in pharmacometrics, focusing on pharmacokinetic and pharmacodynamic (PK/PD) modeling and simulation in drug development, regulation and clinical applications. The symposium will also provide a forum for scientific discussion and collaborative exchange on model-based approaches in drug development. Dr. Bruno's presentation, discussing a model-based approach to support drug development in oncology, will be part of a session focusing on the theory and applications of model-based drug development. The presentation, entitled "Clinical Trial Simulations to Predict Efficacy and Survival Benefit of Anticancer Agents", will take place on October 29, 2007. Dr. Bruno also serves on the symposium's international advisory committee.

"Model-based drug development continues to grow as a value-added method for optimizing decisions in the drug development process," said Shawn O'Connor, president, CEO, and chairman of Pharsight. "Drug development is benefiting from the quantitative application of drug-disease models to simulate expected clinical re
'/>"/>

SOURCE Pharsight Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Why companies dont get invited to the DEMO conference
2. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
3. Wisconsin firms to present at Cleantech venture capital event
4. New Sonic Foundry search engine finds words, phrases in video presentations
5. Lone Wisconsin firm to present at InvestMidwest
6. Sonic Foundry creates search engine for 7,000 expert video presentations
7. InvestMidWest calls for business presentations
8. Wicab to present BrainPort at Boston conference
9. Three more Wisconsin firms to present at venture forum
10. Six Wisconsin firms to present at BIO Mid-America VentureForum
11. New Health and Human Services representative for Midwest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... The ALS Therapy Development Institute announced ... Anelixis Therapeutics , $1.5 million toward the development ... innate immune system. The funding comes from the $4 ... 2014 social media phenomenon known as the “ALS Ice ... directly by the Institute through last year’s Ice Bucket ...
(Date:5/27/2015)... May 27, 2015 Empowering biomedical ... combat disease, Cubresa Inc. today announced its MR ... Compatible in-bore PET Scanner uses silicon photomultiplier detector ... preclinical MRI machines from manufacturers like Bruker and ... in Winnipeg, Canada. “This enables simultaneous PET and ...
(Date:5/27/2015)... , May 27, 2015  CytomX, a ... of cancer, today announced the appointments of ... Cynthia Ladd as senior vice president ... was chief financial officer of Onyx Pharmaceuticals, an ... independent consultant and legal counsel to several leading ...
(Date:5/27/2015)... -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO ) ("NW Bio"), ... cancer, announced today that Dr. Marnix L. Bosch ... making an Industry Expert Theater Presentation at the 2015 ... on Saturday, May 30, 2015, from 3 to 4 ... Place. Dr. Bosch will provide an overview ...
Breaking Biology Technology:Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS 2Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS 3Cubresa Launches Simultaneous PET/MRI Technology 2CytomX Expands Executive Leadership Team 2CytomX Expands Executive Leadership Team 3NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend 2NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend 3
... ... ... CALGARY, Nov. 29 /PRNewswire-FirstCall/ - Resverlogix Corp.,("Resverlogix") (TSX:RVX) is pleased to announce today ... prestigious,Technology Pioneer Award in recognition of its NexVas(TM) Plaque Removal,program. Candidates for this ...
... CAMBRIDGE, England, November 29 Astex Therapeutics Ltd.,today announced ... AT9311,will be presented at the American Society of Hematology,s ... Georgia World Congress,Center, Atlanta, Georgia., AT9283 is an ... BCR-Abl,and Flt-3. There is strong evidence for an important ...
... Nov. 28 Nektar,Therapeutics (Nasdaq: NKTR ) announced ... BMO Capital Markets Focus on Healthcare Conference in New,York ... 2007 at,10:30 a.m. ET., The presentation and Q&A ... a link posted on the Investor Relations, Events,Calendar section ...
Cached Biology Technology:Resverlogix Honoured with World Economic Forum Technology Pioneer Award 2Resverlogix Honoured with World Economic Forum Technology Pioneer Award 3Resverlogix Honoured with World Economic Forum Technology Pioneer Award 4Resverlogix Honoured with World Economic Forum Technology Pioneer Award 5Three Astex Drug Candidates to be Presented at the 2007 American Society of Hematology Annual Meeting 2Three Astex Drug Candidates to be Presented at the 2007 American Society of Hematology Annual Meeting 3
(Date:5/11/2015)... 2015  Through a well-rounded UAS delegation representing private industry, ... strong showing at AUVSI,s Unmanned 2015 conference last week in ... Ohio,s UAS industry met with over 200 hundred ... along the UAS ecosystem. "Our message is ... for Aerospace Rich Knoll . "If you want to ...
(Date:5/8/2015)... , May 8, 2015 Synaptics Inc. (NASDAQ: ... announced that members of the executive management team will present ... Annual Technology, Media and Telecom Conference Date: May 18, ... Boston, MA Cowen and ... Time: 2:45pm ET Location: The New York Palace Hotel, ...
(Date:5/5/2015)... May 5, 2015, NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market, reminds investors and media ... Officer, is presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held ... The three-day conference is organized into a ... in is themed Global Fraud: Where is the Trust ...
Breaking Biology News(10 mins):Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2Synaptics to Present at Upcoming Investor Conferences 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3
... systems biological analysis of genome-scale data from the ... identified that the master gene controlling the biological ... will appear in the latest issue of the ... hypothesis derived from multi-network analysis of Arabidopsis genomic ...
... In roughly five to ten percent of breast cancer cases ... thus, genetic factors play a role here. Alterations in the genes ... breast cancer these are responsible for roughly 25 percent of ... cancers are not attributable to mutations in BRCAI and BRCAII. We ...
... by Mark Hoddle , a biological control specialist ... sharpshooter , a major agricultural pest, from the island ... the South Pacific Ocean. To achieve total pest suppression, ... provides permanent control and can be applied to areas ...
Cached Biology News:Systems biology approach identifies nutrient regulation of biological clock in plants 2Gene variant increases breast cancer risk 2UCR-led research team uses tiny wasp to wipe out major agricultural pest in Tahiti 2UCR-led research team uses tiny wasp to wipe out major agricultural pest in Tahiti 3UCR-led research team uses tiny wasp to wipe out major agricultural pest in Tahiti 4
... Since the early 80s Biosearch ... providing advanced oligonucleotide tools to accelerate ... information. Whether you need dual-labeled FRET ... 100,000 custom oligos for microarray applications, ...
... Concentration Basement Membrane Extract Cultrex HC20+ ... vivo applications where higher protein concentrations ... strength, and elevated levels of tumor ... of lot-to-lot consistency and controlled protein ...
Cultrex 3D Culture Matrix Laminin I....
Request Info...
Biology Products: